200
Participants
Start Date
August 31, 2013
Primary Completion Date
November 18, 2016
Study Completion Date
February 15, 2021
Zilver® PTX® Drug-Eluting Peripheral Stent
Treatment of symptomatic vascular disease of the native above-the-knee femoropopliteal arteries.
Columbia University Medical Center, New York
New York-Presbyterian/ Weill Cornell Medical Center, New York
Holy Spirit Hospital, Camp Hill
Washington Hospital Center, Washington D.C.
Bayview Medical Center, Baltimore
South Carolina Heart Center, Columbia
Greenville Hospital System, Greenville
First Coast Cardiovascular Institute, Jacksonville
The Cardiac and Vascular Institute, Gainesville
University of Florida, Gainesville
Holston Valley Hospital, Kingsport
OhioHealth Research Institute, Columbus
University of Toledo Medical Center, Toledo
Alexian Brothers Medical Center, Elk Grove Village
VA Palo Alto Health Care System, Palo Alto
Stanford University Medical School, Stanford
Beth Israel Deaconess Medical Center, Boston
Cook Research Incorporated
INDUSTRY